Atopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights

被引：59

作者：

Jung, Thomas ^{[1
]}

Stingl, Georg ^{[2
,3
]}

机构：

[1] Novartis Pharma Dev Immunol & Infect Dis Franchis, CH-4056 Basel, Switzerland

[2] Med Univ Vienna, Dept Dermatol, Div Immunol, Vienna, Austria

[3] Med Univ Vienna, Dept Dermatol, Div Allergy & Infect Dis, Vienna, Austria

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2008年 / 122卷 / 06期

关键词：

Atopic dermatitis; skin barrier function; innate immune system; adaptive immune system; filaggrin; T(H)2 cells; T(H)17 cells; immunotherapy; proof-of-concept trial;

D O I：

10.1016/j.jaci.2008.09.042

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Recent insights into the relevance of the epidermal barrier function and its interaction with components of the innate and adaptive immune responses in patients with atopic dermatitis (AD) give rise to a number of novel potential treatment options. In particular, the identification of loss-of-function mutations in the barrier protein filaggrin and of a diminished expression of certain antimicrobial peptides in AD skin stimulates new concepts to think beyond the T(H)1/T(H)2 paradigm. This review will focus on these most recent discoveries and will discuss new and corresponding proof-of-concept trials in patients with AD. It will further speculate on novel ways to restore the homeostasis among the 3 major components in AD skin suspected to be clinically relevant. (J Allergy Clin Immunol 2008;122:1074-81.)

引用

页码：1074 / 1081

页数：8

共 50 条

[31] New insights into T cells and their signature cytokines in atopic dermatitis
Wang, Ao-xue
Landen, Ning Xu
[J]. IUBMB LIFE, 2015, 67 (08) : 601 - 610
[32] Atopic dermatitis: New insights into physiopathology-molecular targets
Darrigade, A-S
Seneschal, J.
[J]. REVUE FRANCAISE D ALLERGOLOGIE, 2018, 58 (03): : 142 - 143
[33] New insights into human atopic dermatitis provided by mouse models
Matsumoto, Kenji
Morita, Hideaki
Nakae, Susumu
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (03) : 722 - 724
[34] Skin microbiota and atopic dermatitis: toward new therapeutic options?
Lacour, J. -Ph.
[J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2015, 142 : S18 - S22
[35] Atopic dermatitis: a review of evolving targeted therapies
Kalamaha, Kadra
Reis, Erin
Newton, Shauna
Roche, Conor
Julson, Janet
Fernandes, Hermina
Rodrigues, Jonathan
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (03) : 275 - 288
[36] Possible new therapeutic strategy to regulate atopic dermatitis through upregulating filaggrin expression
Otsuka, Atsushi
Doi, Hiromi
Egawa, Gyohei
Maekawa, Akiko
Fujita, Tomoko
Nakamizo, Satoshi
Nakashima, Chisa
Nakajima, Saeko
Watanabe, Takeshi
Miyachi, Yoshiki
Narumiya, Shuh
Kabashima, Kenji
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (01) : 139 - +
[37] Atopic Keratoconjunctivitis: Pathophysiology, Clinic, and Potential New Therapeutic Concepts
Lapp, Thabo
Mann, Caroline
Jakob, Thilo
Reinhard, Thomas
Maier, Philip Christian
[J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (05) : 607 - 618
[38] Resveratrol Exerts Therapeutic Effects on Mice With Atopic Dermatitis
Shen, Yanyun
Xu, Jinhua
[J]. WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE, 2019, 31 (11): : 279 - 284
[39] The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis
Fujii, Masanori
[J]. CELLS, 2021, 10 (09)
[40] Atopic Dermatitis-A New Dawn
Weissler, Anne
[J]. PHYSICIAN ASSISTANT CLINICS, 2016, 1 (04) : 661 - +

← 1 2 3 4 5 →